Ignite Creation Date:
2024-05-06 @ 6:24 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05655312
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2022-11-15
Brief Title:
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Sponsor:
Perspective Therapeutics
Organization:
Perspective Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Melanoma Stage III |
| Melanoma Skin |
| Metastatic Melanoma |
| Melanoma Stage IV |
| Melanoma Uveal |
| Mucosal Melanoma |